Outsourcing to the right clinical research organization is critical to the smooth-running of any drug development operation. A CRO can be responsible for handling everything from study planning to pharmacovigilance and delays or errors at any stage can cost a significant amount of both money and time. The right CRO can accelerate operations. The wrong one can delay study completion and even jeopardize approval. Delays in patient recruitment, for example, are estimated to cost between $600,000 and $8 million for each day.